Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LOXL2 | Q9Y4K0 | 5/20 | 0.33 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.33 |
| ▸ | SPIN1 | Q9Y657 | 1/20 | 0.33 |
| ▸ | PNMT | P11086 | 1/20 | 0.31 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.31 |
| ▸ | ST14 | Q9Y5Y6 | 1/20 | 0.31 |
| ▸ | ABAT | P80404 | 1/20 | 0.31 |
| ▸ | LOX | P28300 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21277499 | 0.87 | SHBG (0.33) | SPIN1 | |
| SCHEMBL21277480 | 0.85 | ALDH1A1 (0.37) | LOXL2 | |
| SCHEMBL11436471 | 0.78 | ALDH1A1 (0.43) | LOXL2 | |
| SCHEMBL3673507 | 0.76 | CYP2A6 (0.35) | — | |
| SCHEMBL3667293 | 0.76 | PNMT (0.37) | PNMT | |
| SCHEMBL3676581 | 0.76 | MPO (0.35) | LOXL2 | |
| SCHEMBL10873594 | 0.75 | ALDH1A1 (0.39) | LOXL2 | |
| SCHEMBL9370555 | 0.74 | LOXL2 (0.39) | LOXL2HRH3SPIN1PNMTENPP2 | |
| SCHEMBL91292 | 0.74 | LOXL2 (0.35) | LOXL2HRH3PNMTENPP2ST14 | |
| SCHEMBL17426912 | 0.74 | SHBG (0.53) | ENPP2ABAT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3795561-B1 | METHOD FOR PRODUCING CARBAMATE AND METHOD FOR PRODUCING ISOCYANATE | ASAHI CHEMICAL IND (JP) | 2024-11-06 | — | — | EP | disclosed |
| US-11548975-B2 | Isocyanate composition and method for producing isocyanate polymer | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2023-01-10 | — | — | US | disclosed |
| US-11352319-B2 | Method for producing carbamate and method for producing isocyanate | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2022-06-07 | — | — | US | disclosed |
| US-20210179548-A1 | METHOD FOR PRODUCING CARBAMATE AND METHOD FOR PRODUCING ISOCYANATE | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2021-06-17 | — | — | US | disclosed |
| US-10968168-B2 | Isocyanate production method | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2021-04-06 | — | — | US | disclosed |
| EP-3626705-B1 | ISOCYANATE PRODUCTION METHOD | ASAHI CHEMICAL IND (JP) | 2021-03-24 | — | — | EP | disclosed |
| EP-3795561-A1 | METHOD FOR PRODUCING CARBAMATE AND METHOD FOR PRODUCING ISOCYANATE | Asahi Kasei Kabushiki Kaisha (JP) | 2021-03-24 | — | — | EP | disclosed |
| US-20200115327-A1 | ISOCYANATE PRODUCTION METHOD | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2020-04-16 | — | — | US | disclosed |
| EP-3626705-A1 | ISOCYANATE PRODUCTION METHOD | Asahi Kasei Kabushiki Kaisha (JP) | 2020-03-25 | — | — | EP | disclosed |
| US-20190225739-A1 | ISOCYANATE COMPOSITION AND METHOD FOR PRODUCING ISOCYANATE POLYMER | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2019-07-25 | — | — | US | disclosed |
| EP-2330159-B1 | ELECTRET AND ELECTROSTATIC INDUCTION CONVERSION DEVICE | ASAHI GLASS CO LTD (JP) | 2013-04-24 | — | — | EP | disclosed |
| US-8129869-B2 | Electret and electrostatic induction conversion device | ASAHI GLASS COMPANY, LIMITED (JP) | 2012-03-06 | — | — | US | disclosed |
| US-20110166299-A1 | ELECTRET AND ELECTROSTATIC INDUCTION CONVERSION DEVICE | ASAHI GLASS COMPANY, LIMITED | 2011-07-07 | — | — | US | disclosed |
| EP-2330159-A1 | ELECTRET AND ELECTROSTATIC INDUCTION CONVERSION DEVICE | Asahi Glass Company Limited (JP) | 2011-06-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11352319-B2 | Method for producing carbamate and method for producing isocyanate | CPS1, CA7, CA4 | LOXL2 4326/4885HRH3 505/4885SPIN1 3217/4885 |
| US-11548975-B2 | Isocyanate composition and method for producing isocyanate polymer | IDH3A, IDH2, IDH3B | LOXL2 4033/4885HRH3 1709/4885SPIN1 3907/4885 |
| US-20200115327-A1 | ISOCYANATE PRODUCTION METHOD | IDH3A, ALKBH3, CPS1 | LOXL2 4245/4885HRH3 3088/4885SPIN1 4550/4885 |
| US-20210179548-A1 | METHOD FOR PRODUCING CARBAMATE AND METHOD FOR PRODUCING ISOCYANATE | CPS1, CA7, CA4 | LOXL2 4326/4885HRH3 505/4885SPIN1 3217/4885 |
| US-10968168-B2 | Isocyanate production method | IDH3A, ALKBH3, CPS1 | LOXL2 4245/4885HRH3 3088/4885SPIN1 4550/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.